Daily Beast

Daily Beast
Share

Daily Beast

 •  April 15

Two pharmaceutical companies submitted a joint court filing late Wednesday to prevent the state of Arkansas from using their drugs in the lethal-injection executions of seven death-row inmates over 11 days, which are scheduled to begin next week. According to the legal brief filed to a federal judge, Fresenius Kabi USA and West-Ward Pharmaceuticals...

Daily Beast

 •  April 10

Photo Illustration by Elizabeth Brockway/The Daily Beast Patients with the rarest afflictions are being trained as powerful advocates on Capitol Hill for new drugs and legislation that would help the industry. WASHINGTON—Wearing a blue T-shirt and worn jeans, Marc Yale stood near the welcome pole at the annual Rare Disease Legislative Advocates...

Daily Beast

 •  March 31

Photo Illustration by The Daily Beast Parker Petit says he doesn’t think his ties to the president and Health and Human Services Secretary Tom Price, who oversees the FDA, will benefit his wound care company. Parker Petit, a GOP-friendly biotech executive, has a new nickname since the presidential election. His critics call him “the Trump of...

Daily Beast

 •  March 31

Joshua Roberts/Reuters U.S. Health and Human Services Secretary Tom Price reportedly bought $90,000 worth of pharmaceutical stocks on the same day that he tried to defeat a regulation that would’ve driven drug companies’ profits down. These are not the first allegations of conflicts of interest regarding Price’s stock holdings, and his broker has...

Daily Beast

 •  February 17

When a small Australian biotechnology company, Innate Immunotherapeutics, needed a clinical trial for an experimental drug it hoped to turn into a huge moneymaker, the company landed a U.S. partner where it had high-level connections: Roswell Park Cancer Institute in Buffalo, N.Y. The company is partly owned by Rep. Chris Collins, a wealthy...